Bimekizumab Under Review for Plaque Psoriasis
The BLA is supported by data from the phase 3 BE VIVID, BE READY, and BE SURE studies.
Dermatological Disorders
Clinical Challenge: Asymptomatic Lesion on the Abdomen
A 66-year-old man is referred for evaluation of a lesion on his abdomen. He first noticed the growth approximately 1 year ago, can you make the correct diagnosis?
Clinical Challenge: Rash of the Arms, Legs, and Abdomen
A 34-year-old Hispanic woman is referred by her family practitioner for evaluation of a rash on her arms, legs, and abdomen. The clinician diagnosed the rash as allergic contact dermatitis, administered intramuscular triamcinolone, and placed her on an oral antihistamine. Can you make the correct diagnosis?
FDA to Review Investigational Rosacea Treatment Epsolay
Epsolay is an investigational topical cream that utilizes the Company’s patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules.
Shift Seen to Newer Agents to Treat Psoriasis
Biologics and small molecule inhibitors increasingly used for treatment of newly diagnosed psoriasis.
Newly Diagnosed Lupus Erythematosus Could Potentially Be Drug Induced
A new case of cutaneous lupus erythematosus or systemic lupus erythematosus could potentially be drug induced.
Clinical Challenge: Growth on the Lower Leg
An 84-year-old woman is referred for evaluation of a 0.8cm deeply pigmented papule on her right shin. Can you make the correct diagnosis?
Clinical Challenge: Lesion on the Palm
A 66-year-old man presents for evaluation of a growth on his left palm. He first noted the lesion approximately 1 year ago, and it has increased in size considerably throughout the last 3 to 4 months. Can you make the correct diagnosis?
Winlevi Cream Approved for Acne Vulgaris
The first-in-class topical acne treatment targets the androgen receptor.
Tapinarof Cream Looks Promising for Plaque Psoriasis
The double-blind, vehicle-controlled studies (PSOARING 1 and PSOARING 2) assessed the efficacy and safety of tapinarof in 1025 patients aged 18 to 75 years with plaque psoriasis.
